- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BRAF mutant metastatic melanoma
Total 17264 results
-
Abramson Cancer Center of the University of PennsylvaniaCompletedAdvanced BRAF Mutant MelanomaUnited States
-
Intergruppo Melanoma ItalianoActive, not recruiting
-
Pierre Fabre MedicamentBiotrialActive, not recruitingMelanoma | Metastatic Melanoma | Unresectable Melanoma | BRAF V600 MutationFrance
-
PfizerCompletedColorectal CancerUnited States, Canada, Australia, Germany, Japan, Netherlands, Spain, France, Belgium, Korea, Republic of, Italy, Norway
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
Hospices Civils de LyonCompleted
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
Clinigen, Inc.Prometheus LaboratoriesTerminatedMetastatic MelanomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Roche-GenentechCompletedColorectal CancerUnited States
-
PfizerCompletedLocally Advanced or Metastatic NRAS Mutant MelanomaUnited States, Australia, Germany, Italy, Netherlands
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKlineCompletedUnresectable Melanoma | Stage IV Melanoma | Stage III Melanoma | BRAF Mutant MelanomaUnited States
-
Array Biopharma, now a wholly owned subsidiary...WithdrawnNon-Small Cell Lung CancerUnited States
-
TriHealth Inc.TriHealth Cancer Institute; TriHealth Surgical Institute; TriHealth Ultrasound... and other collaboratorsWithdrawnMelanoma (Skin) | Tumor Skin | BRAF Gene Mutation | Melanoma Stage IIIb-IVM1a | Metastasis SkinUnited States
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
NYU Langone HealthAstraZenecaCompletedMetastatic Colorectal CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Melanoma | Stage IV MelanomaUnited States
-
Genentech, Inc.Completed
-
Abramson Cancer Center of the University of PennsylvaniaCompleted
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
NYU Langone HealthCelldex TherapeuticsTerminated
-
Inge Marie SvaneCompleted
-
Grupo Español Multidisciplinar de MelanomaRoche Farma, S.A; Pivotal S.L.Completed
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Immunovative Therapies, Ltd.CompletedColorectal Cancer MetastaticUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaSouth Africa
-
Yale UniversityNational Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
CelgeneTerminatedNeoplasm MetastasisUnited States, Australia
-
Hoffmann-La RocheCompleted
-
Walter J. StorkusNational Cancer Institute (NCI)Completed
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
Hoffmann-La RocheCompletedMelanomaUnited States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more
-
Hoffmann-La RocheCompleted
-
M.D. Anderson Cancer CenterCompleted
-
Novartis PharmaceuticalsCompletedMelanoma and Brain MetastasesCanada, United States, Australia, France, Germany, Italy, Spain
-
MedImmune LLCCompletedMelanomaItaly, United States, Canada, France
-
University Health Network, TorontoCompleted
-
Duke UniversityWithdrawn
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
GlaxoSmithKlinePfizerCompleted
-
Cascadian Therapeutics Inc.TerminatedAdvanced BRAF-mutant CancersUnited States
-
University of Texas Southwestern Medical CenterCompleted
-
Centre Hospitalier Universitaire de NiceUnknownMalignant Melanoma Stage III | Malignant Melanoma Stage IV
-
GlaxoSmithKlineCompleted
-
Array BioPharmaCompletedMetastatic Colorectal CancerUnited States, Australia, Belgium, Canada, France, Israel, Italy, Netherlands, Singapore, Spain
-
Hospices Civils de LyonUnknown
-
GlaxoSmithKlineNo longer available
-
Hoffmann-La RocheCompleted
-
Genentech, Inc.Terminated